A detailed history of Center Book Partners LP transactions in Vericel Corp stock. As of the latest transaction made, Center Book Partners LP holds 23,203 shares of VCEL stock, worth $1.37 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
23,203
Previous 40,203 42.29%
Holding current value
$1.37 Million
Previous $1.84 Million 46.85%
% of portfolio
0.06%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.25 - $53.56 $718,250 - $910,520
-17,000 Reduced 42.29%
23,203 $980,000
Q2 2024

Aug 12, 2024

BUY
$41.71 - $52.9 $1.13 Million - $1.43 Million
27,064 Added 205.98%
40,203 $1.84 Million
Q1 2024

May 10, 2024

BUY
$32.52 - $52.33 $427,280 - $687,563
13,139 New
13,139 $683,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.79B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.